Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. NEPH
NEPH logo

NEPH Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Nephros Inc (NEPH) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
3.400
1 Day change
0.89%
52 Week Range
6.420
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

NEPH is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock is trading flat at $3.40 with no meaningful momentum signal, no recent news catalyst, and no strong institutional or insider buying. Given the lack of clear upside confirmation and the absence of Intellectia buy signals, the best call is to hold off rather than commit capital immediately.

Technical Analysis

NEPH is showing a neutral technical setup. MACD histogram is slightly positive at 0.0152 but is contracting, which weakens momentum. RSI_6 at 49.343 is neutral, so there is no overbought or oversold edge. Moving averages are converging, suggesting consolidation rather than a confirmed trend. Price is sitting near the pivot level of 3.429, with near-term resistance at 3.658 and support at 3.199. Overall, the chart does not currently show a clear bullish breakout or a strong entry signal.

Positive Catalysts

  • No news in the recent week. Trading sentiment is not strongly negative, as hedge funds are neutral and insiders are neutral. The stock trend model suggests modest upside over the next week and month, but not enough to qualify as a clear catalyst. There are no recent congress trading signals or major influencer purchases reported.

Neutral/Negative Catalysts

  • No recent news-driven catalyst is present. Hedge funds are neutral, insiders are neutral, and there is no recent congress trading activity. Technical momentum is weak and consolidating, with no AI Stock Pick or SwingMax signal today. The stock also lacks valuation and financial snapshot support in the provided data, limiting confidence in a fresh buy decision.

Financial Performance

Latest quarter financial data is not available in the provided snapshot due to an error, so a quarter-by-quarter growth assessment cannot be made. Because the latest quarter season is missing, there is no reliable evidence here of accelerating revenue, profit growth, or improving fundamentals to support a long-term buy.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so there is no visible Wall Street upgrade/downgrade or target revision trend to support a bullish case. Based on the available information, the pros view is weak because there is no strong institutional, insider, or catalyst support; the cons view is stronger because momentum is flat and the stock lacks confirmation for an immediate entry.

Wall Street analysts forecast NEPH stock price to rise
1 Analyst Rating
Wall Street analysts forecast NEPH stock price to rise
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 3.370
sliders
Low
8
Averages
8
High
8
Current: 3.370
sliders
Low
8
Averages
8
High
8
Maxim
Maxim
NULL -> Buy
upgrade
$6
AI Analysis
2025-08-08
Reason
Maxim
Maxim
Price Target
$6
AI Analysis
2025-08-08
upgrade
NULL -> Buy
Reason
Maxim raised the firm's price target on Nephros to $6 from $4.50 and keeps a Buy rating on the shares. The company's Q2 results saw revenue, gross margins, and earnings all above consensus estimates, the analyst tells investors in a research note.

People Also Watch